Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

BUY
$37.44 - $46.51 $9,921 - $12,325
265 New
265 $11,000
Q3 2021

Nov 12, 2021

SELL
$52.17 - $70.2 $260 - $351
-5 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$68.86 - $83.34 $68 - $83
-1 Reduced 16.67%
5 $0
Q1 2021

May 11, 2021

BUY
$76.15 - $111.94 $456 - $671
6 New
6 $0
Q4 2020

Feb 12, 2021

SELL
$96.85 - $148.25 $8,716 - $13,342
-90 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$122.47 - $213.56 $11,022 - $19,220
90 New
90 $12,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.